Owner-Reported Clinical Outcomes of a Homeopathic Proprietary Preparation for the Treatment of Upper Respiratory and Nasal Disorders in Companion Animals

Background: Nasal and upper respiratory conditions are frequent issues in dogs and cats, presenting symptoms like sneezing, nasal obstruction, and various types of discharge. These can result from allergies, infections, foreign objects, or anatomical factors. While many cases respond to reatment, underlying issues often cause relapses. The investigational product offers apotential new approach for managing these nasal and sinus diseases in companion animals.Objectives: The primary objective of this PRO (Patient Reported Outcome) study was to assess the efficacy and safety HomeoPet® Nose Relief in Upper Respiratory Tract Disease Symptoms. Methods: This study was done on patient-reported outcome (PRO) data collected via an internet questionnaire. It is afacilitator-driven survey similar to previous studies17,18,19.Results: The study included 221 real-world patients split over four mall animal species, with dogs and cats being in the majority. Runny Nose 94 (44.76%), Sneezing 73 34.76%), Watery eyes 55 (26.19%), Nasal blockage 35 (16.67%), Upper respiratory infection 17 (8.1%), 6 (2.86%), Cold 30 (14.29%), Allergies 20 (9.52%), Nasal discharge 93 (44.29%) and Sinusitis 8 (11.94%) cases p< 0.0000001. In 61 (29.05%) pets, the symptoms were constant, while 71 (33.81%) had intermittent symptoms. The ANOVA revealed that there was an extremely weak downhill relationship between the pet type and efficacy of the medicine (p<0.0001). The analysis or correlation revealed a statistically significant, moderately high correlation between the frequency of symptoms and efficacy of Nose Relief in relieving the symptoms (R=0.408096, p<0.0001). Frequency of daily dose and age had a moderately low relationship with efficacy, in different directions. It can be administered orally-directly, in food, or water-with dosing 1 to 3 times daily generally sufficient. More frequent dosing was well tolerated and may be beneficial in acute or chronic nasal and upper respiratory conditions, offering a novel therapeutic option in veterinary care.Conclusion: Nose Relief, was found to be safe and effective for managing upper respiratory tract infections (URTIs) in companion animals.

Authors

Publication Details

Journal
Open Access Journal of Veterinary Science & Research
Published
2025-01-01
DOI
https://doi.org/10.23880/oajvsr-16000285
Primary Topic
Complementary and Alternative Medicine Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Owner-Reported Clinical Outcomes of a Homeopathic Proprietary Preparation for the Treatment of Upper Respiratory and Nasal Disorders in Companion Animals

Thomas Farrington, I. Ruebert Smith
Open Access Journal of Veterinary Science & Research
Complementary and Alternative Medicine Studies
article

Owner-Reported Clinical Outcomes of a Homeopathic Proprietary Preparation for the Treatment of Upper Respiratory and Nasal Disorders in Companion Animals

Thomas Farrington, I. Ruebert Smith
article en

Abstract

Background: Nasal and upper respiratory conditions are frequent issues in dogs and cats, presenting symptoms like sneezing, nasal obstruction, and various types of discharge. These can result from allergies, infections, foreign objects, or anatomical factors. While many cases respond to reatment, underlying issues often cause relapses. The investigational product offers apotential new approach for managing these nasal and sinus diseases in companion animals.Objectives: The primary objective of this PRO (Patient Reported Outcome) study was to assess the efficacy and safety HomeoPet® Nose Relief in Upper Respiratory Tract Disease Symptoms. Methods: This study was done on patient-reported outcome (PRO) data collected via an internet questionnaire. It is afacilitator-driven survey similar to previous studies17,18,19.Results: The study included 221 real-world patients split over four mall animal species, with dogs and cats being in the majority. Runny Nose 94 (44.76%), Sneezing 73 34.76%), Watery eyes 55 (26.19%), Nasal blockage 35 (16.67%), Upper respiratory infection 17 (8.1%), 6 (2.86%), Cold 30 (14.29%), Allergies 20 (9.52%), Nasal discharge 93 (44.29%) and Sinusitis 8 (11.94%) cases p< 0.0000001. In 61 (29.05%) pets, the symptoms were constant, while 71 (33.81%) had intermittent symptoms. The ANOVA revealed that there was an extremely weak downhill relationship between the pet type and efficacy of the medicine (p<0.0001). The analysis or correlation revealed a statistically significant, moderately high correlation between the frequency of symptoms and efficacy of Nose Relief in relieving the symptoms (R=0.408096, p<0.0001). Frequency of daily dose and age had a moderately low relationship with efficacy, in different directions. It can be administered orally-directly, in food, or water-with dosing 1 to 3 times daily generally sufficient. More frequent dosing was well tolerated and may be beneficial in acute or chronic nasal and upper respiratory conditions, offering a novel therapeutic option in veterinary care.Conclusion: Nose Relief, was found to be safe and effective for managing upper respiratory tract infections (URTIs) in companion animals.

Open Access Journal of Veterinary Science & ResearchVol. 10(2)
Openalex Percentile: Top 73%
Complementary and Alternative Medicine Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.